HERON THERAPEUTICS, INC. short interest in 2022
In 2022, HERON THERAPEUTICS, INC.'s disclosed short interest ran from 36.26% of shares outstanding on 14 Jan 2022 to 21.05% on 30 Dec 2022, a change of -15.21 percentage points. The year's high was 39.45% on 29 Jul 2022 and its low 21.05% on 30 Dec 2022, averaging 32.76% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.85 days on 15 Feb 2022. Full history: HERON THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 36.26% (14 Jan 2022)
- End of year
- 21.05% (30 Dec 2022)
- Change
- -15.21 pp
- High
- 39.45% (29 Jul 2022)
- Low
- 21.05% (30 Dec 2022)
- Average
- 32.76%
- Highest days to cover
- 22.85 (15 Feb 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 36.26% | 21.85 | |
| 31 Jan 2022 | 33.99% | 14.92 | |
| 15 Feb 2022 | 34.50% | 22.85 | |
| 28 Feb 2022 | 34.02% | 17.05 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 33.14% | 10.46 | |
| 31 Mar 2022 | 38.46% | 14.04 | |
| 14 Apr 2022 | 36.42% | 18.93 | |
| 29 Apr 2022 | 36.23% | 21.44 | |
| 13 May 2022 | 36.08% | 10.87 | 10-Q filed, results (8-K) |
| 31 May 2022 | 36.07% | 17.03 | |
| 15 Jun 2022 | 38.04% | 12.94 | |
| 30 Jun 2022 | 35.56% | 11.84 | |
| 15 Jul 2022 | 39.21% | 13.95 | |
| 29 Jul 2022 | 39.45% | 21.33 | |
| 15 Aug 2022 | 33.13% | 7.54 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 31.81% | 11.93 | |
| 15 Sep 2022 | 31.88% | 9.79 | |
| 30 Sep 2022 | 32.56% | 7.11 | |
| 14 Oct 2022 | 28.43% | 14.19 | |
| 31 Oct 2022 | 28.04% | 15.68 | |
| 15 Nov 2022 | 23.89% | 10.23 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 23.74% | 15.15 | |
| 15 Dec 2022 | 24.26% | 8.61 | |
| 30 Dec 2022 | 21.05% | 6.76 |
See also: HERON THERAPEUTICS, INC.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.